Kathie Hermayer to Humans
This is a "connection" page, showing publications Kathie Hermayer has written about Humans.
Connection Strength
0.458
-
Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era. Am J Med Sci. 2020 10; 360(4):423-426.
Score: 0.028
-
Newer oral and noninsulin therapies to treat type 2 diabetes mellitus. Cleve Clin J Med. 2016 May; 83(5 Suppl 1):S18-26.
Score: 0.021
-
Hospital Guidelines for Diabetes Management and the Joint Commission-American Diabetes Association Inpatient Diabetes Certification. Am J Med Sci. 2016 Apr; 351(4):333-41.
Score: 0.021
-
The Diabetes Initiative of South Carolina Celebrates Over 20 Years of Professional Diabetes Education. Am J Med Sci. 2016 Apr; 351(4):325-6.
Score: 0.020
-
Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.
Score: 0.019
-
A case of apathetic thyroid storm with resultant hyperthyroidism-induced hypercalcemia. Am J Med Sci. 2013 Oct; 346(4):338-40.
Score: 0.017
-
The diabetes initiative of South Carolina and the 18th Annual Diabetes Fall Symposium for Health Care Professionals. Am J Med Sci. 2013 Apr; 345(4):260-262.
Score: 0.017
-
Diabetes and driving safety: science, ethics, legality and practice. Am J Med Sci. 2013 Apr; 345(4):263-265.
Score: 0.017
-
Ocular disease, knowledge and technology applications in patients with diabetes. Am J Med Sci. 2013 Apr; 345(4):266-270.
Score: 0.017
-
Oral health and type 2 diabetes. Am J Med Sci. 2013 Apr; 345(4):271-273.
Score: 0.017
-
Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013 Apr; 345(4):274-277.
Score: 0.017
-
All grown up: moving from pediatric to adult diabetes care. Am J Med Sci. 2013 Apr; 345(4):278-283.
Score: 0.017
-
Pharmacotherapy of obesity: clinical treatments and considerations. Am J Med Sci. 2013 Apr; 345(4):284-288.
Score: 0.017
-
Improving diabetes management with mobile health technology. Am J Med Sci. 2013 Apr; 345(4):289-295.
Score: 0.017
-
South Carolina guidelines for diabetes care 2013. Am J Med Sci. 2013 Apr; 345(4):296-301.
Score: 0.017
-
Brief update on the burden of diabetes in South Carolina. Am J Med Sci. 2013 Apr; 345(4):302-306.
Score: 0.017
-
A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4399-406.
Score: 0.016
-
Impact of improvement efforts on glycemic control and hypoglycemia at a university medical center. J Hosp Med. 2009 Jul; 4(6):331-9.
Score: 0.013
-
Outcomes of a cardiothoracic intensive care web-based online intravenous insulin infusion calculator study at a Medical University Hospital. Diabetes Technol Ther. 2007 Dec; 9(6):523-34.
Score: 0.012
-
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag. 2007; 3(6):823-32.
Score: 0.011
-
Treatment of lipids and type 2 diabetes. Curr Cardiol Rep. 2004 Nov; 6(6):443-50.
Score: 0.009
-
A case of unilateral adrenal hyperplasia: the diagnostic dilemma of hyperaldosteronism. Endocr Pract. 2000 Mar-Apr; 6(2):153-8.
Score: 0.007
-
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
Score: 0.007
-
Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management. Am J Med Sci. 2019 11; 358(5):332-339.
Score: 0.006
-
Physician office-based diabetes care: comparison to guidelines for care. J S C Med Assoc. 1998 Nov; 94(11):485-91.
Score: 0.006
-
Community programs and screening related to diabetes and its complications. J S C Med Assoc. 1998 Nov; 94(11):493-500.
Score: 0.006
-
Clinical implications of the insulin resistance syndrome. Clin Cornerstone. 1998; 1(3):13-28.
Score: 0.006
-
Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy. Stem Cells Transl Med. 2018 01; 7(1):11-19.
Score: 0.006
-
Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
Score: 0.005
-
Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
Score: 0.005
-
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
Score: 0.005
-
Critical Care Glucose Point-of-Care Testing. Adv Clin Chem. 2016; 76:97-121.
Score: 0.005
-
Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose. Curr Diab Rep. 2015 Mar; 15(3):10.
Score: 0.005
-
Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care. 2014 Nov; 37(11):2934-9.
Score: 0.005
-
Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes. J Diabetes Complications. 2013 Nov-Dec; 27(6):637-41.
Score: 0.004
-
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013 Aug; 36(8):2169-74.
Score: 0.004
-
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
Score: 0.004
-
The prevalence of significant left-right hip bone mineral density differences among black and white women. Osteoporos Int. 2009 Dec; 20(12):2079-85.
Score: 0.003
-
Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006 Dec; 34(12):2974-8.
Score: 0.003
-
In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism. 2004 Aug; 53(8):969-76.
Score: 0.002
-
Pure testosterone-producing virilizing adrenocortical tumours in young women. BJU Int. 2003 Dec; 92 Suppl 3:e10-e11.
Score: 0.002
-
Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital. J S C Med Assoc. 2002 Dec; 98(8):305-10.
Score: 0.002
-
Diagnosis and management of pheochromocytoma during pregnancy: a case report. Am J Med Sci. 1999 Sep; 318(3):186-9.
Score: 0.002
-
Diabetes patient education. J S C Med Assoc. 1998 Nov; 94(11):478-84.
Score: 0.002
-
Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8.
Score: 0.002
-
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes. 1996 Jun; 45(6):762-7.
Score: 0.001